Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Hydromorphone Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Fresenius Kabi USA, LLC (Revised 04/24/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Unavailable | Backordered. Next release not available at this time. Check wholesalers for inventory. | Demand increase for the drug |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Available | Check wholesalers for inventory | |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Unavailable | Backordered. Next release not available at this time. Check wholesaler for inventory. | Other |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Unavailable | Backordered. Next release not available at this time. Check wholesaler for inventory. | Demand increase for the drug |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Available | Check wholesalers for inventory | |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Available | Check wholesalers for inventory | Demand increase for the drug |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Available | Check wholesalers for inventory | Demand increase for the drug |
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Available | Check wholesalers for inventory | |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Available | Check wholesalers for inventory | Demand increase for the drug |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Unavailable | Backordered. Next release May 2025. Check wholesalers for inventory. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Revised 04/11/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Unavailable | Additional lots will be available in the May 2025 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-2341-41) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
Hospira, Inc., a Pfizer Company (Reverified 04/23/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Available | ||
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Unavailable | Next Delivery: August 2025; Estimated Recovery: March 2026 | Other |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Available | ||
| Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Unavailable | Next Delivery: June 2025; Estimated Recovery: December 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Available | ||
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Unavailable | Next Delivery: April 2025; Estimated Recovery: September 2025 | Demand increase for the drug |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Unavailable | Next Delivery: May 2025; Estimated Recovery: September 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Unavailable | Next Delivery: April 2025; Estimated Recovery: June 2025 | Other |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Available | ||
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Available | ||
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Available |
Teva Pharmaceuticals USA, Inc. (Revised 04/22/2025)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Limited Availability | Estimated recovery: November 2025 | Shortage of an active ingredient |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Available | Estimated recovery: April 2025 | Shortage of an active ingredient |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Available | Shortage of an active ingredient |